Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to present at four investor conferences in February and March 2019.
Conference details:
8th Annual SVB Leerink Global Healthcare Conference
Date: Thursday, February 28, 2019
Presentation time: 1:30 p.m. ET
Location: New York, NY
A live webcast of the presentation can be accessed here.
Cowen 39th Annual Health Care Conference
Date: Monday, March 11, 2019
Presentation Time: 3:30 p.m. ET
Location: Boston, MA
A live webcast of the presentation can be accessed here.
BioCapital Europe 2019*
Date: Thursday, March 14, 2019
Presentation Time: 3:20 p.m. CET
Location: Amsterdam
William Blair 9th Annual Cancer Immunotherapy Conference*
Date: Wednesday, March 20, 2019
Presentation Time: 10:30 a.m. ET
Location: New York, NY
An archived recording of the webcasts noted above will also be available under Events & Webcasts in the Investors section of the Company’s website.
[*] This event will not be webcast.
